Week50, 2022
1. Influenza activity is elevated and increasing across most of the U.S., with 12.8% of respiratory specimens testing positive for influenza this week.

2. Clinical labs reported 82.8% of positive specimens as Influenza A and 17.2% as Influenza B; public health labs reported 81.9% Influenza A and 18.1% Influenza B, with A(H1N1) accounting for 78.2% of subtyped A viruses.

3. Outpatient respiratory illness visits represent 5.1% of healthcare visits, exceeding the national baseline for the seventh consecutive week, with increases in all age groups and regions.

4. The cumulative hospitalization rate is 11.3 per 100,000, the second-highest for this point in the season in over a decade, with hospitalizations primarily affecting older adults and young children.

5. Weekly influenza-associated deaths accounted for 0.3% of total deaths, with no pediatric deaths reported this week but 14 total this season so far.

6. Approximately 5.3 million illnesses, 54,000 hospitalizations, and 3,200 deaths have occurred in this flu season to date.

7. Antigenic and genetic analysis of circulating viruses shows good match with current vaccine strains, which remain recommended and available for individuals 6 months and older.

8. CDC noted cases of co-circulating respiratory viruses like RSV and SARS-CoV-2 contributing to respiratory illness rates.

9. The percentage of clinical specimens testing positive and flu hospitalizations are increasing compared to previous weeks, reflecting intensified flu activity.

10. CDC continues to provide integrated surveillance of co-circulating viruses and anticipates continued elevated influenza activity in the following weeks.